课题基金 / 基金详情

项目摘要

项目成果

MICHAEL Chiao-An WU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The human microbiome is integrally related to a vast range of human disorders and represents an imperative gateway toward mitigating the burden of these diseases, particularly as the microbiome is eminently modifiable. This has culminated in microbially oriented risk reduction and clinical interventions, which have proven efficacious in diverse situations ranging from infections to cancer immunotherapy. However, despite some high- profile successes, many other studies have failed. A central theme underlying these failures, and even many of the success stories, is our fundamentally limited understanding of how microbes interact with each other, with host genomics, and with outcomes. Recently, efforts to assess and map these relationships are taking place within large-scale profiling studies, but unfortunately, the tools used for elucidating these connections may be underpowered, difficult to interpret, or even subject to severe false positives due to strong underlying assumptions. Therefore, motivated by problems within three of the largest and richest microbiome profiling studies, this proposal seeks to fill critical gaps in the methodological literature by addressing four major areas. Specifically, we aim to develop a comprehensive suite of tools for (1) enhanced microbial co-occurrence network construction; (2) enhanced discovery of SNPs and rare variants associated with individual microbial taxa; and (3) assessing the role of microbes through Mendelian Randomization. These approaches are all based on rigorous prior data emphasizing the importance of the problems as well as the limitations of existing strategies. Our work is motivated by and will directly enable analyses in three of the largest and richest microbiome profiling studies, including the MEC and SOL cohorts which study the gut microbiome, and the PIN cohort, which explores the vaginal microbiome in pregnancy. Accordingly, the methods we develop have the potential to improve our fundamental knowledge of the microbiome and propel the field towards enhanced risk reduction and clinical interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Statistical Methods for Large Scale Microbiome Studies of Cardiovascular Disease Risk
  • 批准号:
    10371985
  • 项目类别:
  • 资助金额:
    $44.13万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL Chiao-An WU
  • 依托单位:
Statistical Methods for Large Scale Microbiome Studies of Cardiovascular Disease Risk
  • 批准号:
    10656159
  • 项目类别:
  • 资助金额:
    $43.41万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL Chiao-An WU
  • 依托单位:
Joint Analysis of Microbiome and Other Genomic Data Types
Joint Analysis of Microbiome and Other Genomic Data Types
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: